# The serotonin theory of depression: a systematic umbrella review of the evidence.

- **DOI:** [10.1038/s41380-022-01661-0](https://doi.org/10.1038/s41380-022-01661-0)
- **Rating:** Strong (3.8 out of 5)
- **Verdict:** A consequential umbrella review undermines the low-serotonin account of depression, but the underlying evidence is heterogeneous and often low quality.
- **Framework version:** v5.8
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-08-17
- **Evaluation page:** https://www.nabu.science/paper/10.1038%2Fs41380-022-01661-0

## Key claims

1. The main areas of serotonin research provide no consistent evidence of there being an association between serotonin and depression, and no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations.
   - Support: Supported
   - Type: Primary finding
   - Basis: certainty-graded findings broadly converge, but several non-genetic domains remain small, confounded, or very low certainty
   - Location: Abstract; Discussion, p. 3253
2. The two largest and highest quality studies of the SERT gene, one genetic association study and one collaborative meta-analysis, revealed no evidence of an association with depression, or of an interaction between genotype, stress and depression.
   - Support: Well-supported
   - Type: Secondary
   - Basis: two high-certainty, very large analyses consistently report null gene and gene-stress results
   - Location: Abstract; Results, p. 3252
3. Some evidence was consistent with the possibility that long-term antidepressant use reduces serotonin concentration.
   - Support: Tentative
   - Type: Secondary
   - Basis: the inference rests primarily on one cohort sensitivity analysis and indirect supporting evidence
   - Location: Abstract; Discussion, pp. 3253–3254
4. Two meta-analyses of overlapping studies examining the 5-HT1A receptor, and three meta-analyses of overlapping studies examining SERT binding showed weak and inconsistent evidence of reduced binding in some areas.
   - Support: Tentative
   - Type: Secondary
   - Basis: overlapping, medication-confounded imaging studies provide inconsistent and very-low-certainty evidence
   - Location: Abstract; Results, pp. 3251–3252

## Strengths

- **Six domains synthesised in one framework** The paper brings biochemical, receptor, transporter, depletion, genetic, and gene-environment evidence into one umbrella synthesis and distinguishes high-certainty null findings from very-low-certainty signals.
  - Dimension: contribution
  - Location: Methods, six research areas; Table 3; Results, Overall results
- **Certainty ratings shape the conclusions** AMSTAR-2, adapted AMSTAR-2, and STREGA assessments feed into modified GRADE ratings that are reflected in the overall results and discussion rather than reported as a detached checklist.
  - Dimension: methodological rigour
  - Location: Methods, Data analysis; Table 3; Results, Overall results
- **Overlapping evidence is not double-counted** The review does not combine overlapping meta-analyses, thereby avoiding duplicate weighting of primary studies, and it explicitly explains this decision.
  - Dimension: methodological rigour
  - Location: Abstract; Methods, Data analysis

## Limitations

- **Initial screening lacked independent duplication** Each team member searched and screened assigned domains, with full-team discussion only when uncertainty arose. This is not independent dual screening and increases the risk of missed eligible evidence.
  - Dimension: methodological rigour
  - Location: Methods, Data analysis
- **Recency rule may shape inclusion** The review includes only the five most recent studies when more than five are available, excluding eleven otherwise eligible reports. The effect of this rule on domain-level conclusions is not fully tested.
  - Dimension: methodological rigour
  - Location: Methods, inclusion criterion 5; Figure 1
- **Underlying evidence is often fragile** Most included reviews satisfied fewer than half of the appraisal criteria, and many non-genetic studies were small or unable to exclude prior antidepressant effects. These limitations constrain the certainty of several domains underlying the headline synthesis.
  - Dimension: positioning
  - Location: Results, Search results and quality rating; Table 3; Discussion, limitations paragraphs

## Reliability checks

Caveats (4 of 4 checks).

- **Internal coherence:** Noted. The paper is internally coherent overall and transparently documents source-data discrepancies and its selective table-display rule. These presentation and reconstruction choices warrant attention but do not contradict the central interpretation.
- **Research conduct:** Noted. The protocol registration, subsequent update, data-availability statement, and relevant interests are disclosed. The antidepressant-discontinuation-related roles create interpretive context but no evidence of concealment or threshold-level conduct failure.
- **Reference integrity:** Clean. 69 of 69 checkable references verified
  - 75 references in manuscript
  - 6 have no canonical index record — counted, but not index-checkable
  - 2 references confirmed by manual review
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
